There’s endless discussion online about which NAD boosting vitamin supplement to take — Nicotinamide Riboside “NR” (FAQs) (Anecdotes) or NMN (FAQs and Anecdotes). As a result, potential customers are often left confused without any idea which to choose. The following transcript may provide some clarity.
Month: March 2021
In numerous recent interviews (Here and Here), top Harvard Alzheimer’s expert Dr Rudy Tanzi discussed plans to initiate 2 human clinical studies using NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). In one study, Dr Tanzi will focus on Alzheimer’s patients. And in the other, which was posted on ClinicalTrials.gov earlier this week Dr Tanzi will focus on long-haul COVID patients experiencing persistent cognitive and physical symptoms. You may remember that Dr Tanzi knows a lot about NR through both personal supplementation (“I religiously take Tru Niagen“) AND his association with the NFL’s New England Patriots. As a result, many have been eagerly awaiting these two clinical trials. Here’s more on the COVID trial posted earlier this week:
“As Long As You Have Access To Nicotinamide Riboside (NR), There Is Really No Purpose For Using NMN”
While NAD boosting supplement NMN (FAQs and Anecdotes) remains incredibly popular especially in China, the folks at Chromadex continue to make the case that Nicotinamide Riboside “NR” (FAQs) (Anecdotes) is your better option. Chairman Frank Jaksch made the case in early March. And last week, Dr Andrew Shao weighed in as well in an interview with NUTRA Ingredients Asia. See HERE.
We know that there’s enormous interest in studying Nicotinamide Riboside “NR” (FAQs) (Reviews) in the science community. A quick look at the 50+ ongoing or completed clinical trials says it all. But who are these scientists? Chromadex CEO Rob Fried talked about some of them at the Oppenheimer Health Care Conference yesterday.
What should you expect to feel from supplementing with Nicotinamide Riboside “NR” (FAQs) (Reviews)? Do consumers tend to increase their dose over time? Here’s what Chromadex CEO Rob Fried said at the Oppenheimer Health Care Conference yesterday:
A popular YouTube channel called Bestie (3.4m subs) posted a short but substantive video this week with Nicotinamide Riboside “NR” (FAQs) (Reviews) topping a list of “6 Supplements That’ll Help You Build A Better Brain” (Turmeric, Lion’s Mane Mushrooms, Seafood, Vitamin D3). Transcript and video embedded below.
While we’ve heard from many consumers reporting life-changing experiences thanks to supplementing with Nicotinamide Riboside “NR” (FAQs) (Reviews), we’re now hearing more and more from pet owners too. This latest story was submitted yesterday (please consider sharing your own NAD+ supplement experience below).
As a public company, Chromadex has few opportunities each year to talk openly with the public about Nicotinamide Riboside “NR” (FAQs) (Reviews). Last evening was one of those times. The following are key quotes from Chromadex CEO Rob Fried and Chairman Frank Jaksch during management’s Q4 2020 earnings call.
In advance of this week’s earnings call, Wall Street analysts at B Riley published a note today on Chromadex and recent developments relating to Nicotinamide Riboside “NR” (FAQs) (Reviews). The following are key excerpts.
We’ve covered this often asked and endlessly debated question repeatedly at RaisingNAD. Scientists say Nicotinamide Riboside (NR) is the better choice — and Nestlé Health Science (a subsidiary of Nestlé), which recently launched a new product with NR as the key ingredient, calls NR: “the most efficient NAD+ precursor“. Yet, NMN (FAQs and Anecdotes) remains incredibly popular. So what should you do? Well, while Chromadex Chairman Frank Jaksch is obviously in the NR camp, he recently made a compelling case in plain English why the choice should be obvious.
Chromadex Chairman: “Mounting Evidence Has Linked Compromised NAD+ Status to the Hallmarks of Aging”
In a rare appearance, Chromadex Founder and current Executive Chairman Frank Jaksch joined the “Cellular Health: The Next Big Market Opportunity“ webcast last week to discuss NAD, Nicotinamide Riboside “NR” (FAQs) (Anecdotes), NMN (FAQs and Anecdotes), aging and more. According to his bio, Jaksch is not your ordinary Executive Chairman. He currently oversees research, strategy, and operations for ChromaDex, with a focus on scientific and novel products for the pharmaceutical and nutraceutical markets. During this webcast, Jaksch had a lot of substantive things to say. As a result, we’re posting a transcript of his entire ~10-minute presentation.